Bioequivalence Study of Atazanavir 300 mg Capsule

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2006
The purpose of this clinical research study is to assess the bioequivalence of atazanavir administered as a single 300 mg capsule relative to two atazanavir 150 mg capsules in healthy subjects.
Epistemonikos ID: 0803cae5a7bc998b685ab10e611d712db32ab976
First added on: Dec 01, 2021